GlaxoSmithKline Grows Theravance Stake: Investing in the Pipeline – Seeking Alpha

GlaxoSmithKline Grows Theravance Stake: Investing in the Pipeline
Seeking Alpha
Chief among the products of their collaboration to date is Relovair, heir to the throne of Advair, GSK's best-selling medicine for asthma attacks and COPD.

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *